TrialDrugs in R&D2015

Population Pharmacokinetics and Pharmacodynamics of GSK961081 (Batefenterol), a Muscarinic Antagonist and β2-Agonist, in Moderate-to-Severe COPD Patients: Substudy of a Randomized Trial.

Claire L Ambery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.